Medical News Today: What is juvenile psoriatic arthritis?
When psoriatic arthritis occurs in children or adolescents, doctors classify it as juvenile psoriatic arthritis. Those with the condition experience symptoms of both rheumatoid arthritis and psoriasis, including pain, stiffness, swelling of the joints, and patches of flaky, crusty skin. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 30, 2018 Category: Consumer Health News Tags: Psoriatic Arthritis Source Type: news

Arthritis: Severe joint pain could be a symptom of gout - what you need to know
ARTHRITIS types include osteoarthritis, psoriatic arthritis and gout. Although the former is the most common, there are other types to be aware of. These four symptoms, including severe joint pain, may indicate gout. (Source: Daily Express - Health)
Source: Daily Express - Health - June 15, 2018 Category: Consumer Health News Source Type: news

Arthritis symptoms: Do this exercise to soothe knee pain
ARTHRITIS symptoms consist of joint stiffness, pain and swelling, among others. Types of the condition include rheumatoid arthritis, psoriatic arthritis and osteoarthritis. You ’re more likely to develop the condition if you’re older, overweight or have a previous injury. This joint exercise can help treat the symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 27, 2018 Category: Consumer Health News Source Type: news

Cancer Risk Raised in Psoriatic Arthritis
(MedPage Today) -- Highest risk was for nonmelanoma skin cancer (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 25, 2018 Category: Primary Care Source Type: news

Medical News Today: Can you have RA and PsA at the same time?
There are many types of arthritis. Psoriatic arthritis is linked to the skin condition psoriasis, where the immune system overreacts, resulting in psoriasis rashes. Rheumatoid arthritis also causes the immune system to overreact, but results in stiffness in the joints. Learn about the difference between the two here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 24, 2018 Category: Consumer Health News Tags: Psoriatic Arthritis Source Type: news

Arthritis: Try this exercise to relieve pain in your hands
RHEUMATOID arthritis symptoms include pain in the joints, stiffness and swelling. This is just one type of arthritis, with others including psoriatic arthritis and osteoarthritis. You can try these easy hand exercises to reduce the symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2018 Category: Consumer Health News Source Type: news

Medical News Today: How is psoriatic arthritis different from osteoarthritis?
There are many different types of arthritis. Each one causes a problem in the joints, which can lead to pain or damage. Two distinct types that people often get are psoriatic arthritis and osteoarthritis. Each has its own different causes and symptoms. Learn more about the difference between them here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 13, 2018 Category: Consumer Health News Tags: Psoriatic Arthritis Source Type: news

Arthritis: Alarming signs that you could have psoriatic arthritis - you should know these
ARTHRITIS is a painful condition where sufferers usually experience swelling, tenderness and stiffness around affected joints. Psoriatic arthritis is just one type of the condition, which can affect anywhere on the body including the knees, hands, feet and spine. These are the symptoms of the condition you should know. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2018 Category: Consumer Health News Source Type: news

Arthritis: Warning signs that you could have this type of the condition
ARTHRITIS is a painful condition where sufferers usually experience swelling, tenderness and stiffness around affected joints. Psoriatic arthritis is just one type of the condition, which can affect anywhere on the body including the knees, hands, feet and spine. These are the symptoms of the condition you should know. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2018 Category: Consumer Health News Source Type: news

Arthritis: Alarming signs that you could have psoriatic arthritis - you should know these
ARTHRITIS is a painful condition where sufferers usually experience swelling, tenderness and stiffness around affected joints. Psoriatic arthritis is just one type of the condition, which can affect anywhere on the body including the knees, hands, feet and spine. These are the symptoms of the condition you should know. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2018 Category: Consumer Health News Source Type: news

Adalimumab Clears Nail Disease in Psoriatic Arthritis
(MedPage Today) -- Nail involvement often overlooked (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 2, 2018 Category: Dermatology Source Type: news

Arthritis pain - eight warning signs of psoriatic arthritis including painful buttocks
ARTHRITIS pain symptoms include inflammation, restricted movement, and joint stiffness. But, these are the warning signs for psoriatic arthritis - a type of arthritis that may develop if you have the skin condition psoriasis. (Source: Daily Express - Health)
Source: Daily Express - Health - April 28, 2018 Category: Consumer Health News Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Ask Can You Exercise with Psoriatic Arthritis
Can You Exercise with Psoriatic Arthritis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 24, 2018 Category: General Medicine Source Type: news

Ask What Not to Eat with Psoriatic Arthritis
What Not to Eat with Psoriatic Arthritis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 23, 2018 Category: General Medicine Source Type: news

Ask the First Signs of Psoriatic Arthritis
What Are the First Signs of Psoriatic Arthritis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 23, 2018 Category: General Medicine Source Type: news

Ask How Do They Test for Psoriatic Arthritis
How Do They Test for Psoriatic Arthritis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 23, 2018 Category: General Medicine Source Type: news

Ask Can Psoriatic Arthritis Go Away on Its Own
Can Psoriatic Arthritis Go Away on Its Own? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 23, 2018 Category: General Medicine Source Type: news

Low Doses of Etanercept to Maintain Remission in PsA Low Doses of Etanercept to Maintain Remission in PsA
Find out how psoriatic arthritis patients who have achieved sustained remission with etanercept may benefit from a dosing interval increase.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 23, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Secukinumab Improves Active Psoriatic Arthritis Secukinumab Improves Active Psoriatic Arthritis
In patients with active psoriatic arthritis (PsA), secukinumab improves symptoms and inhibits radiographic disease progression, researchers report.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 12, 2018 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Ardon Health Announces Taltz Distribution
Ardon Health has been selected to Eli Lilly’s Taltz Distribution Network for the treatment of adults with moderate to severe plaque psoriasis and active psoriatic arthritis.(PRWeb April 12, 2018)Read the full story at http://www.prweb.com/releases/2018/04/prweb15401179.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 12, 2018 Category: Pharmaceuticals Source Type: news

Ask How Serious Is Psoriatic Arthritis
How Serious Is Psoriatic Arthritis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 10, 2018 Category: General Medicine Source Type: news

ASK THE GP: Will having the shingles jab give us chicken pox?
The Daily Mail's resident GP answers your queries on everything and anything. This week, he deals with the risks of shingles immunisation and effective treatments for psoriatic arthritis. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2018 Category: Consumer Health News Source Type: news

EMA Committee Backs Remicade Biosimilar Zessly EMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2018 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Autoinjected Secukinumab a Hit in Psoriatic Arthritis
(MedPage Today) -- Benefits seen over a year in skin and joint manifestations (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 16, 2018 Category: Dermatology Source Type: news

What is psoriatic arthritis? FOUR signs that you have the painful joint condition
ARTHRITIS pain affects about 10 million people in the UK. But, if you have the skin condition psoriasis, you could be at risk of psoriatic arthritis. These are symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - February 28, 2018 Category: Consumer Health News Source Type: news

Novel Interleukin Inhibitors for Psoriatic Arthritis Novel Interleukin Inhibitors for Psoriatic Arthritis
What does the most recent data tell us about the efficacy and safety of newer interleukin inhibitors for the treatment of psoriatic arthritis?Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 15, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Tofacitinib for PsA: From Phase III to Approval
(MedPage Today) -- In mid-December, tofacitinib was approved for use in active psoriatic arthritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 28, 2017 Category: Primary Care Source Type: news

FDA OKs Tofacitinib (Xeljanz) for Active Psoriatic Arthritis FDA OKs Tofacitinib (Xeljanz) for Active Psoriatic Arthritis
The JAK inhibitor is indicated for patients who have failed to respond adequately or are intolerant to methotrexate or other disease-modifying antirheumatic drugs.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 18, 2017 Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news

Depression remains a taboo subject at work
Poll finds people would rather talk about sex or money worries than mental health Related items fromOnMedica High sugar diet linked to depression in men Anxiety and depression linked to higher cancer death risk Depression raises risk of developing psoriatic arthritis (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 18, 2017 Category: UK Health Source Type: news

Pfizer Announces FDA Approval of Xeljanz (tofacitinib) and Xeljanz XR for the Treatment of Active Psoriatic Arthritis
December 14, 2017 - Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has approved Xeljanz 5 mg twice daily (BID) and Xeljanz XR (tofacitinib) extended release 11 mg once daily (QD) for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2017 Category: Drugs & Pharmacology Source Type: news

AmalgamRX to launch stress reduction app for patients with psoriasis, psoriatic arthritis
Digital therapy platform AmalgamRX has just announced the upcoming launch of its new app, Beyond, which aims to help patients living with psoriasis and psoriatic arthritis providing them resources to manage stress. (Source: mobihealthnews)
Source: mobihealthnews - December 13, 2017 Category: Information Technology Source Type: news

New GRAPPA and EULAR Recommendations for Managing PsA New GRAPPA and EULAR Recommendations for Managing PsA
GRAPPA and EULAR have provide updated recommendations regarding the management and treatment of psoriatic arthritis.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

BAD Guidelines for Biologic Therapy for Psoriasis 2017 BAD Guidelines for Biologic Therapy for Psoriasis 2017
The British Association of Dermatologists provides evidence-based recommendations on the use of biologic therapies for the treatment of psoriasis and psoriatic arthritis in adults and children.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Psoriatic arthritis is the second approved indication for Taltz in the United States. (Source: ConsultantLive)
Source: ConsultantLive - December 12, 2017 Category: Internal Medicine Authors: Rheumatology Network Staff Tags: Psoriatic Arthritis Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Psoriatic arthritis is the second approved indication for Taltz in the United States. (Source: CancerNetwork)
Source: CancerNetwork - December 12, 2017 Category: Cancer & Oncology Authors: Rheumatology Network Staff Tags: Psoriatic Arthritis Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Ixekizumab significantly improves symptoms of psoriatic arthritis in patients naive to prior biologic therapy and in patients who had failed prior to biologic therapy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 6, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Lilly's Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
INDIANAPOLIS, Dec. 1, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Taltz (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 1, 2017 Category: Drugs & Pharmacology Source Type: news

Bariatric Tx Tied to Lower Psoriasis Risk in Obese Patients (CME/CE)
(MedPage Today) -- Benefit did not extend to psoriatic arthritis (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 27, 2017 Category: Dermatology Source Type: news

Tofacitinib is Effective in Psoriatic Arthritis
This agent was superior to placebo in patients who had not responded to or could not take a conventional DMARD. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Psoriatic Arthritis Source Type: news

Tofacitinib is Effective in Psoriatic Arthritis
This agent was superior to placebo in patients who had not responded to or could not take a conventional DMARD. (Source: ConsultantLive)
Source: ConsultantLive - November 21, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Psoriatic Arthritis Source Type: news

Subcutaneous Secukinumab Relieves Psoriatic Arthritis Subcutaneous Secukinumab Relieves Psoriatic Arthritis
The interleukin-17A inhibitor is effective and safe, according to first results from the ongoing FUTURE5 study, the largest controlled trial of a biologic for psoriatic arthritis to date.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Long-Term Use of Lilly's Taltz(R) (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Taltz also demonstrated improvements in key secondary measures, including skin clearance, at 52 weeks INDIANAPOLIS, Nov. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today patients with active psoria... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, Psoriatic Arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2017 Category: Pharmaceuticals Source Type: news

New phase 2 data show treatment with tremfya ® (guselkumab) improved psoriatic arthritis symptoms through one year
Longer-Term Results Demonstrate Continued Efficacy of Anti-Interleukin 23 Monoclonal Antibody TREMFYA ® in Improving Joint and Skin Symptoms Associated with Active Psoriatic Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 7, 2017 Category: Pharmaceuticals Source Type: news

Golimumab Gets FDA Nod for Two New Indications Golimumab Gets FDA Nod for Two New Indications
The TNF-alpha inhibitor significantly improved the signs and symptoms of psoriatic arthritis and ankylosing spondylitis in phase 3 testing.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Simponi Aria (golimumab) for the Treatment of Adults With Active Psoriatic Arthritis or Active Ankylosing Spondylitis
Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab), the only fully-human anti-tumor necrosis factor (TNF)-alpha therapy administered via a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

Tofacitinib Shows Promise in Psoriatic Arthritis Tofacitinib Shows Promise in Psoriatic Arthritis
Tofacitinib is better than placebo for psoriatic arthritis that has responded poorly to treatment with conventional disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Magnetic Resonance Imaging in Psoriatic Arthritis Magnetic Resonance Imaging in Psoriatic Arthritis
A new study explores the important role axial and peripheral MRI scans can play in the evaluation and management of patients with psoriatic arthritis.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

What Are the Different Types of Psoriatic Arthritis?
Title: What Are the Different Types of Psoriatic Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 10/2/2017 12:00:00 AMLast Editorial Review: 10/2/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 2, 2017 Category: Rheumatology Source Type: news